Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-11-18 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
S | Class A Ordinary Share | D | 17000 | $21.04 - $21.04 | $357,680 |
2024-11-18 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
M | Class A Ordinary Share | A | 10000 | $1.59 - $1.59 | $15,900 |
2024-11-06 | Kiniksa Pharmaceuticals International, plc | Patel Sanj K
(CHAIRMAN & CEO) |
S | Class A Ordinary Share | D | 89561 | $23.00 - $23.00 | $2,059,903 |
2024-11-06 | Kiniksa Pharmaceuticals International, plc | Patel Sanj K
(CHAIRMAN & CEO) |
M | Class A Ordinary Share | A | 89561 | $1.59 - $1.59 | $142,401 |
2024-10-15 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
S | Class A Ordinary Share | D | 17000 | $26.87 - $26.87 | $456,790 |
2024-10-15 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
M | Class A Ordinary Share | A | 10000 | $1.59 - $1.59 | $15,900 |
2024-10-04 | Kiniksa Pharmaceuticals International, plc | Megna Michael R
(CHIEF ACCOUNTING OFFICER) |
F | Class A Ordinary Share | D | 82 | $24.48 - $24.48 | $2,007 |
2024-10-04 | Kiniksa Pharmaceuticals International, plc | BAKER JULIAN
(Director) |
A | Class A Ordinary Shares | A | 9460 | $0.00 - $0.00 | $0 |
2024-09-23 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
S | Class A Ordinary Share | D | 17500 | $24.99 - $24.99 | $437,325 |
2024-09-23 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
M | Class A Ordinary Share | A | 10000 | $1.59 - $1.59 | $15,900 |
2024-08-27 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
S | Class A Ordinary Share | D | 17500 | $26.91 - $26.91 | $470,925 |
2024-08-27 | Kiniksa Pharmaceuticals International, plc | Tessari Eben
(CHIEF OPERATING OFFICER) |
M | Class A Ordinary Share | A | 10000 | $1.59 - $1.59 | $15,900 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Patel Sanj K
(CHAIRMAN & CEO) |
S | Class A Ordinary Share | D | 136124 | $23.25 - $27.01 | $3,491,946 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Patel Sanj K
(CHAIRMAN & CEO) |
M | Class A Ordinary Share | A | 136124 | $1.59 - $1.59 | $216,437 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Ragosa Mark
(CHIEF FINANCIAL OFFICER) |
S | Class A Ordinary Share | D | 24248 | $24.79 - $24.79 | $601,107 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Ragosa Mark
(CHIEF FINANCIAL OFFICER) |
M | Class A Ordinary Share | A | 24248 | $11.10 - $11.10 | $269,152 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Paolini John F.
(CHIEF MEDICAL OFFICER) |
S | Class A Ordinary Share | D | 22000 | $25.03 - $27.87 | $578,964 |
2024-07-23 | Kiniksa Pharmaceuticals International, plc | Paolini John F.
(CHIEF MEDICAL OFFICER) |
M | Class A Ordinary Share | A | 22000 | $1.86 - $1.86 | $40,920 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |